Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy Of BEZ235, a Dual PI3-Kinase /mTOR Inhibitor, In Adult Patients With Relapsed Or Refractory Acute Leukemia: Results Of a Phase I Study

Lydia Wunderle, MD, Susanne Badura, Fabian Lang, MD, Andrea Wolf, Eberhard Schleyer, MD, Hubert Serve, MD, Nicola Goekbuget, MD, Heike Pfeifer, MD, Gesine Bug, MD, PhD, Oliver G. Ottmann, MD

Blood (2013) 122 (21): 2675.

https://doi.org/10.1182/blood.V122.21.2675.2675

Published: 2013

Journal Articles

Oral Etoposide Is Equivalent to Intravenous Administration within the CHOEP-Regimen - Results of a Comparative Pharmacokinetic Study.

Frank P. Kroschinsky, MD, Kai Friedrichsen, Juliane Mueller, MD, Mathias Haenel, MD, Gerhard Ehninger, Eberhard Schleyer, MD

Blood (2006) 108 (11): 4662.

https://doi.org/10.1182/blood.V108.11.4662.4662

Published: 2006

Journal Articles

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Frank P. Kroschinsky, MD, Eberhard Schleyer, MD, Kristina Hoelig, MD, Uta Oelschlaegel, PhD, Rainer Ordemann, MD, Kirsten Poppe-Thiede, MD, Markus A. Schaich, MD, Claudia Rutt, MD, Gerhard Ehninger, MD

Blood (2005) 106 (11): 5321.

https://doi.org/10.1182/blood.V106.11.5321.5321

Published: 2005

Journal Articles

Single-Dose Pegfilgrastim after Chemotherapy Is Highly Effective in Enhancing the Mobilization of Autologous CD34+ Peripheral Blood Stem Cells in Patients with Lymphoid Malignancies and Solid Tumors.

Frank Kroschinsky, MD, Kristina Hoelig, MD, Uwe Platzbecker, MD, Eberhard Schleyer, MD, Rainer Ordemann, MD, Astrid Haack, Markus Schaich, MD, Martin Bornhaeuser, MD, Gerhard Ehninger, MD

Blood (2004) 104 (11): 2922.

https://doi.org/10.1182/blood.V104.11.2922.2922

Published: 2004

Journal Articles

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Frank Kroschinsky, MD, Kristina Hoelig, MD, Rainer Ordemann, MD, Astrid Haack, Kirsten Poppe-Thiede, MD, Matthias Blechschmidt, MD, Gabi Rall, Martin Bornhaeuser, MD, Eberhard Schleyer, MD, Claudia Rutt, Gerhard Ehninger, MD

Blood (2004) 104 (11): 5003.

https://doi.org/10.1182/blood.V104.11.5003.5003

Published: 2004

Journal Articles

Rapamycin Has Biological Activity in a Subset of Patients with Myelodysplastic Syndrome - Results of a Phase I/II Trial.

Uwe Platzbecker, MD, Michael Haase, MD, Regina Herbst, MD, Anette Hanel, MD, Karsten Voigtmann, Christian Thiede, MD, Brigitte Mohr, MD, Eberhard Schleyer, MD, Traugott Leopold, MD, Mathias Hanel, MD, Gerhard Ehninger, MD, Martin Bornhauser, MD

Blood (2004) 104 (11): 1449.

https://doi.org/10.1182/blood.V104.11.1449.1449

Published: 2004

Journal Articles

Activity and Induction of Apoptosis of the Specific Tyrosine Kinase Inhibitor AMN 107 in bcr-abl + Cell Lines and in Imatinib Resistant Primary Cells from CML Patients.

Philipp Le Coutre, MD, Gökben Baskaynak, MD, Ingo Tamm, MD, Jörg Westermann, MD, Justus Duyster, MD, Malte v. Bonin, MD, Stefan Pursche, MD, Petra Mayer, MD, Paul Manley, Ph.D., Jürgen Mestan, Ph.D., Eberhard Schleyer, M.D., Bernd Dorken, M.D.

Blood (2004) 104 (11): 762.

https://doi.org/10.1182/blood.V104.11.762.762

Published: 2004

Journal Articles

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

Martin Bornhäuser, Barry Storer, John T. Slattery, Frederick R. Appelbaum, H. Joachim Deeg, John Hansen, Paul J. Martin, George B. McDonald, W. Garrett Nichols, Jerald Radich, Ann Woolfrey, Andreas Jenke, Eberhard Schleyer, Christian Thiede, Gerhard Ehninger, Claudio Anasetti

Blood (2003) 102 (3): 820–826.

https://doi.org/10.1182/blood-2002-11-3567

Published: 2003

Journal Articles

Activity of Thymidine Kinase and of Polymerase α as Well as Activity and Gene Expression of Deoxycytidine Deaminase in Leukemic Blasts Are Correlated With Clinical Response in the Setting of Granulocyte-Macrophage Colony-Stimulating Factor–Based Priming Before and During TAD-9 Induction Therapy in Acute Myeloid Leukemia

Gerlinde Jahns-Streubel, Christoph Reuter, Ulrike Auf der Landwehr, Michael Unterhalt, Eberhard Schleyer, Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann

Blood (1997) 90 (5): 1968–1976.

https://doi.org/10.1182/blood.V90.5.1968

Published: 1997

NARROW

Safety and Efficacy Of BEZ235, a Dual PI3-Kinase /mTOR Inhibitor, In Adult Patients With Relapsed Or Refractory Acute Leukemia: Results Of a Phase I Study

Oral Etoposide Is Equivalent to Intravenous Administration within the CHOEP-Regimen - Results of a Comparative Pharmacokinetic Study.

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Single-Dose Pegfilgrastim after Chemotherapy Is Highly Effective in Enhancing the Mobilization of Autologous CD34+ Peripheral Blood Stem Cells in Patients with Lymphoid Malignancies and Solid Tumors.

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Rapamycin Has Biological Activity in a Subset of Patients with Myelodysplastic Syndrome - Results of a Phase I/II Trial.

Activity and Induction of Apoptosis of the Specific Tyrosine Kinase Inhibitor AMN 107 in bcr-abl + Cell Lines and in Imatinib Resistant Primary Cells from CML Patients.

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only